Human induced pluripotent stem cells (hiPSCs) and CRIPSR-Cas gene-editing are scientific breakthrough technologies. In combination, they provide a unique opportunity to mechanistically dissect disease mechanisms, develop patient-specific disease models and significantly advance drug development. However, hiPSCs are inherently sensitive cells and a critical bottleneck in the efficient generation of gene-edited hiPSCs is the generation of single-cell derived (clonal) cultures. Existing methods for single-cell isolation are often harsh on cells, manually tedious and/or do not guarantee sufficient proof of monoclonality. Here, we detail automated single-cell isolation workflows utilizing a novel type of culture chamber that is uniquely suited to easily visualise and document single cells, as well as track outgrowing cultures. Our streamlined and automated workflows facilitate a gentle isolation and culture process, producing market-leading/industry-leading hiPSC single-cell cloning efficiencies without the need for complex protocols or instrumentation.
The European Laboratory Research & Innovation Group
Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis
Get the App
Get this event information on your mobile by going to the Apple or Google Store and search for 'myEventflo'